Benzinga | Aug 5, 2020 04:01PM EDT

Arrowhead Pharmaceuticals Q3 EPS $(0.13) Misses $(0.12) Estimate, Sales $27.38M Miss $28.91M Estimate

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 161.9 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $27.38 million which missed the analyst consensus estimate of $28.91 million by 5.31 percent. This is a 35.89 percent decrease over sales of $42.70 million the same period last year.